Yuri Yanishevski - Concepedia

Concepedia

Author

Yuri Yanishevski

St. Jude Children's Research Hospital

Also Known As

Y Yanishevski, Yuri Yanishevski

15

Publications

1.1K

Citations

13

H-Index

34

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center University of Minnesota Parker Hughes Cancer Center

YY

About

Yuri Yanishevski is an author at St. Jude Children's Research Hospital specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	621
2	Health Sciences	2	2	230
3	Allergy	2	2	275
4	Natural Sciences	1	1	262
5	Biochemistry	1	1	262

Yuri Yanishevski

×

14

Publications

1.1K

Citations

13

H-Index

	Year	Citations
Enhanced proteolysis of thiopurine <i>S</i> -methyltransferase (TPMT) encoded by mutant alleles in humans ( <i>TPMT</i> ∗ <i>3</i> <i>A</i> , <i>TPMT</i> ∗ <i>2</i> ): Mechanisms for the genetic polymorphism of TPMT activity Hung-Liang Tai, Eugene Y. Krynetski, Erin G. Schuetz, Proceedings of the National Academy of Sciences GeneticsT-regulatory CellImmunologyTpmt MrnaHuman Polymorphism	1997	262
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia M V Relling, Yuri Yanishevski, J.F. Nemec, Leukemia Hematological MalignancyMolecular PharmacologyAntimetabolite PharmacologyMedicineMixed-phenotype Acute Leukemia	1998	188
Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase. Eugene Y. Krynetski, Natalia F. Krynetskaia, Yuri Yanishevski, Molecular Pharmacology	1995	118
Differences in Folylpolyglutamate Synthetase and Dihydrofolate Reductase Expression in Human B-Lineage versus T-Lineage Leukemic Lymphoblasts: Mechanisms for Lineage Differences in Methotrexate Polyglutamylation and Cytotoxicity A J Galpin, John D. Schuetz, Eric Masson, Molecular Pharmacology	1997	117
Reduced Folate Carrier Expression in Acute Lymphoblastic Leukemia: A Mechanism for Ploidy but not Lineage Differences in Methotrexate Accumulation Vladimir M. Belkov, Eugene Y. Krynetski, John D. Schuetz, Blood	1999	117
In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. Fatih M. Uckun, Rama Krishna Narla, Tamer Zeren, PubMed Vivo ToxicityBreast OncologyMedicineCutaneous BiologyProtein Tyrosine Kinase	1998	78
Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia H Nishigaki, Chikako Ito, Atsushi Manabe, Blood	1997	49
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia John C. Panetta, Yuri Yanishevski, Ching‐Hon Pui, Cancer Chemotherapy and Pharmacology Hematological MalignancyVivo Methotrexate AccumulationMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematology	2002	42
Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia H Nishigaki, Chikako Ito, Atsushi Manabe, Blood	1997	40
Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys. Fatih M. Uckun, Yuri Yanishevski, Nilgun E. Tumer, PubMed ToxinologyImmunotoxicologyB43-pokeweed Antiviral ProteinLaboratory ImmunologyHumoral Response	1997	29

Page 1